Quantbot Technologies’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Quantbot Technologies’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,947	Closed	-$267K	–	2305
2022 Q1	$267K	Buy	+9,947	New	+$334K	0.02%	771
2021 Q4	–	Sell	-1,372	Closed	-$91K	–	2057
2021 Q3	$91K	Sell	1,372 -7,528	-85%	-$536K	0.01%	984
2021 Q2	$694K	Buy	+8,900	New	+$658K	0.05%	456
2019 Q4	–	Sell	-300	Closed	-$11K	–	1696
2019 Q3	$11K	Buy	+300	New	+$13.1K	﹤0.01%	1165

Other funds holding TPTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Quantbot Technologies's TPTX Position: Q2 2022 in Review

Quantbot Technologies sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2022, closing a stake of 9,947 shares — an estimated $267K sold.

Quantbot Technologies first reported a position in TPTX in Q3 2019 and held it in 4 quarters. The position peaked at $694K in Q2 2021. 208 funds tracked by Wall St. Rank hold TPTX as of Q2 2022.

Quantbot Technologies reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Quantbot Technologies sold 9,947 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $267K.
Quantbot Technologies first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
Quantbot Technologies's Turning Point Therapeutics, Inc. Common Stock position peaked at $694K in Q2 2021.
208 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.